[Brain abscess in children: ten years of experience in a third level pediatric hospital]

Martín Brizuela1, Guadalupe Pérez2, Soledad Martiren2

  • 1Servicio de Control Epidemiológico e Infectología, Hospital de Pediatría "Prof. Dr. Juan P. Garrahan", Ciudad Autónoma de Buenos Aires. martin.brizuela1984@gmail.com.

Insights

This study details pediatric brain abscess cases, identifying common bacteria like anaerobes and Streptococcus viridans. Prompt treatment, including surgical drainage and antibiotics, is crucial for better outcomes in children with brain abscess.

Area of Science:

  • Pediatric Infectious Diseases
  • Neurology
  • Microbiology

Background:

  • Brain abscess is a serious focal infection with a reported incidence of 0.3-1.3 cases per 100,000 person-years.
  • Understanding the specific epidemiological and clinical features in pediatric populations is essential for timely diagnosis and management.

Purpose of the Study:

  • To describe the epidemiology, clinical presentation, and microbiology of brain abscess in children.
  • To analyze treatment strategies and outcomes for pediatric brain abscess patients.

Main Methods:

  • Retrospective analysis of 38 children diagnosed with brain abscess between April 2005 and December 2015.
  • Data collected included patient demographics, predisposing factors, symptom onset, lesion characteristics, treatment, and outcomes.

Main Results:

  • The median age was 132 months, with 24 males. Predisposing factors were present in 25 children, and the median symptom onset to visit was 7 days.
  • Anaerobes, Streptococcus viridans, and Staphylococcus aureus were the most common pathogens. Surgical drainage was performed in 34 patients.
  • Median antibiotic treatment was 56 days, and median hospitalization was 43 days, with a 3% lethality rate.

Conclusions:

  • Pediatric brain abscess requires prompt diagnosis and management, often involving surgical intervention and prolonged antibiotic therapy.
  • Identifying common causative agents like anaerobes and Streptococcus viridans aids in guiding empirical antibiotic choices.
  • The study highlights a low lethality rate, suggesting effective treatment protocols for pediatric brain abscess.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
509
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
480
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
377
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
332
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
831